# The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome

> **NCT06824324** · PHASE1,PHASE2 · COMPLETED · sponsor: **Yassir R. Al-khannaq** · enrollment: 14 (actual)

## Conditions studied

- Myofacial Pain Syndrome

## Interventions

- **DRUG:** intramuscular Botulinum Toxin

## Key facts

- **NCT ID:** NCT06824324
- **Lead sponsor:** Yassir R. Al-khannaq
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-12
- **Primary completion:** 2024-11-04
- **Final completion:** 2025-01-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2025-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06824324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06824324, "The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06824324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*